Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meike Heurich

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Viruses|March 6, 2021
Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus InfectionsBen M Flude, Giulio Nannetti, Paige Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskMeike Heurich, Ruben Martínez-Barricarte, Nigel J Francis, et al.
Molecular Immunology|April 17, 2015
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndromeRubén Martínez-Barricarte, Meike Heurich, Andrés López-Perrote, et al.
The Journal of Clinical Investigation|September 21, 2010
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationRubén Martínez-Barricarte, Meike Heurich, Francisco Valdes-Cañedo, et al.
Molecular Psychiatry|January 13, 2019
Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stressMelanie Föcking, Sophie Sabherwal, Hannah M Cates, et al.
Biological Psychiatry|March 18, 2019
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and ChildrenFrancisco Madrid-Gambin, Melanie Föcking, Sophie Sabherwal, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
Brain, Behavior, and Immunity|March 31, 2024
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studiesJonah F Byrne, Colm Healy, Melanie Föcking, et al.
JCI Insight|March 23, 2018
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficienciesDavid A Slatter, Charles L Percy, Keith Allen-Redpath, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Viruses|March 6, 2021
Targeting the Complement Serine Protease MASP-2 as a Therapeutic Strategy for Coronavirus InfectionsBen M Flude, Giulio Nannetti, Paige Mitchell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 11, 2011
Common polymorphisms in C3, factor B, and factor H collaborate to determine systemic complement activity and disease riskMeike Heurich, Ruben Martínez-Barricarte, Nigel J Francis, et al.
Molecular Immunology|April 17, 2015
The molecular and structural bases for the association of complement C3 mutations with atypical hemolytic uremic syndromeRubén Martínez-Barricarte, Meike Heurich, Andrés López-Perrote, et al.
The Journal of Clinical Investigation|September 21, 2010
Human C3 mutation reveals a mechanism of dense deposit disease pathogenesis and provides insights into complement activation and regulationRubén Martínez-Barricarte, Meike Heurich, Francisco Valdes-Cañedo, et al.
Molecular Psychiatry|January 13, 2019
Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: evidence for a role of stressMelanie Föcking, Sophie Sabherwal, Hannah M Cates, et al.
Biological Psychiatry|March 18, 2019
Integrated Lipidomics and Proteomics Point to Early Blood-Based Changes in Childhood Preceding Later Development of Psychotic Experiences: Evidence From the Avon Longitudinal Study of Parents and ChildrenFrancisco Madrid-Gambin, Melanie Föcking, Sophie Sabherwal, et al.
Brain, Behavior, and Immunity|January 14, 2024
Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptomsColm Healy, Jonah Byrne, Subash Raj Suasi, et al.
Schizophrenia Bulletin|March 14, 2023
Association of Complement and Coagulation Pathway Proteins With Treatment Response in First-Episode Psychosis: A Longitudinal Analysis of the OPTiMiSE Clinical TrialSubash Raj Susai, Melanie Föcking, David Mongan, et al.
Brain, Behavior, and Immunity|March 31, 2024
Plasma complement and coagulation proteins as prognostic factors of negative symptoms: An analysis of the NAPLS 2 and 3 studiesJonah F Byrne, Colm Healy, Melanie Föcking, et al.
JCI Insight|March 23, 2018
Enzymatically oxidized phospholipids restore thrombin generation in coagulation factor deficienciesDavid A Slatter, Charles L Percy, Keith Allen-Redpath, et al.
Pageof 3